Devic Neuromyelitis Optica

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-17
Clinical Trial Update: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders [Phase 2]
Phase 2 clinical trial evaluating autologous mesenchymal stem cells for neuromyelitis optica spectrum disorders (Devic's syndrome).